Effect of an EDA-A1 gene mutant on the proliferation and cell cycle distribution of cultured human umbilical vein endothelial cells
- Authors:
- Published online on: December 18, 2015 https://doi.org/10.3892/etm.2015.2952
- Pages: 535-539
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Abstract
Ectodysplasin (EDA) gene mutation is associated with hypohidrotic ectodermal dysplasia (HED). The aim of this study was to investigate the effect of ectodysplasin, transcript variant 1 (EDA‑A1) on the proliferation and cell cycle of ECV304 human umbilical vein endothelial cells (HUVECs). Recombinant eukaryotic expression vectors containing mutant (M) and wild‑type (W) EDA‑A1 coding sequences, pcDNA3.1 (‑)‑EDA‑A1‑M and pcDNA3.1 (‑)‑EDA‑A1‑W, respectively, were transfected into ECV304 cells. The EDA‑A1 gene was amplified by reverse transcription polymerase chain reaction (RT‑PCR), and the protein was detected by western blotting. The EDA‑A1 gene and protein were detected in ECV304 cells transfected with pcDNA3.1 (‑)‑EDA‑A1‑M and pcDNA3.1 (‑)‑EDA‑A1‑W, but not in ECV304 cells transfected with empty plasmid or cells that had not undergone transfection. Compared with the control group, the EDA‑A1 gene mutant significantly decreased the proliferation of ECV304 cells and its inhibition rate was 45.70% (P<0.01), whereas the wild‑type EDA‑A1 gene did not cause such growth inhibition (P>0.05). A significant increase of the fraction of cells in the G0/G1 phase of the cell cycle was observed in the ECV304 cells of the mutant group compared with wild type group, with an increase in the S phase population and a concomitant reduction in the G2/M phase population (P<0.05). These results indicate that compared with the wild‑type gene, transfection with a mutant EDA‑A1 gene inhibited the proliferation and cell cycle of cultured HUVECs.
